COVID-19 lockdown impact on the physical activity of adults with progressive muscle diseases.
Sarah F Roberts-LewisMark AshworthClaire M WhiteMichael R RosePublished in: BMJ neurology open (2021)
From our findings, we can infer specific evidence-based recommendations about how to redress inactivity secondary to COVID-19 restrictions for adults with progressive muscle diseases. These recommendations are likely to be generalisable to other groups who are vulnerable to functional decline secondary to prolonged inactivity.